| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/14/2008 | US20080038339 Solid dosage form comprising solid dispersion and method for producing the same |
| 02/14/2008 | US20080038338 Tetracycline Package Formulations |
| 02/14/2008 | US20080038337 Smectite DispersibleTablets and the Preparation Thereof |
| 02/14/2008 | US20080038336 Solid pharmaceutical composition containing a combination of an intestinal motility regulating agent and an antiflatulent |
| 02/14/2008 | US20080038335 Method, formulation, and use thereof for improved oral absorption of pharmaceuticals or nutrients |
| 02/14/2008 | US20080038334 Method for producing and a system for cooling a hot-filled softgel capsule |
| 02/14/2008 | US20080038333 Formulations For Poorly Soluble Drugs |
| 02/14/2008 | US20080038332 Stable pharmaceutical formulation comprising atorvastatin calcium |
| 02/14/2008 | US20080038331 Enantiomerically pure S-etifoxine, pharmaceutical compositions thereof and methods of their use |
| 02/14/2008 | US20080038330 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds of the lower respiratory tract |
| 02/14/2008 | US20080038329 T-cell activating agent |
| 02/14/2008 | US20080038328 Pasting Preparation |
| 02/14/2008 | US20080038327 comprising S-sulfonated keratin associated with a water soluble polymer through hydrogen bonding and further comprising a protein cross-linking agent |
| 02/14/2008 | US20080038326 Multilayered Dosing Systems |
| 02/14/2008 | US20080038325 comprising biocompatible polymer, polyalcohol, and medicinal plant extract obtained from mixture of Houttuynia cordata, elm, persimmon leaves, celandine, pine tree leaves, Canavalia gladiata and an herb; prepared by irradiation to achieve crosslinking and three-dimensional structure; wound dressings |
| 02/14/2008 | US20080038324 Sanitary Thin Paper for Domestic Use |
| 02/14/2008 | US20080038323 Methods for Improving Liver Clearance of Xenobiotic Substances in an Animal |
| 02/14/2008 | US20080038322 Stabilized Bacteriophage Formulations |
| 02/14/2008 | US20080038320 Compositions and methods for enhancing vasodilation |
| 02/14/2008 | US20080038319 Stimulating protective antibodies against enterotoxigenic Escherichia coli; carbonated beverages |
| 02/14/2008 | US20080038315 Process for agent retention in biological tissues |
| 02/14/2008 | US20080038313 Systems, methods, and compositions for mixing and applying lyophilized biomaterials |
| 02/14/2008 | US20080038312 Insertable or implantable medical devices suitable for gene therapy regimens |
| 02/14/2008 | US20080038309 Use of polypeptides obtained through systematic mutations of single amino acids of human and non-human Box-A of HMGB1 to prevent and/or antagonize pathologies induced by HMGB1 |
| 02/14/2008 | US20080038308 Silencing RNA molecules and their use in bone formation |
| 02/14/2008 | US20080038305 Ceramic Bulking Agent |
| 02/14/2008 | US20080038302 Collapsible water-containing capsules |
| 02/14/2008 | US20080038301 Personal care product comprising collapsible water-containing capsules |
| 02/14/2008 | US20080038298 Medicament and System for the Percutaneous Preparation of Medicaments |
| 02/14/2008 | US20080038281 Model membrane systems |
| 02/14/2008 | US20080038222 Composition Comprising Colony Stimulating Factor for Treatment of a Localised Bacterial Infection and Bacterial Related Disease |
| 02/14/2008 | US20080038220 Testosterone Gels Comprising Propylene Glycol as Penetration Enhancer |
| 02/14/2008 | US20080038209 Nicotine Delivery Product and Method for Producing It |
| 02/14/2008 | US20080038208 Pharmaceutical/cosmetic compositions comprising the lysine-d-proline-valine tripeptide |
| 02/14/2008 | US20080038189 RNA interference mediated inhibition of aurorakinase B and its combinations as anticancer therapy |
| 02/14/2008 | US20080035143 Human-powered dry powder inhaler and dry powder inhaler compositions |
| 02/14/2008 | DE20221822U1 Dünnflüssige, sprühbare W/O Emulsionen Low-viscosity, sprayable W / O emulsions |
| 02/14/2008 | DE102006037378A1 Vorrichtung und Verfahren zur dosierten Wirkstoffabgabe bei rauchlosen Zigaretten Apparatus and method for dose drug delivery in smokeless cigarettes |
| 02/14/2008 | DE102006019419B4 Aktuator insbesondere eines Endoroboters Actuator in particular a endorobot |
| 02/14/2008 | CA2660427A1 Pharmaceutical composition |
| 02/14/2008 | CA2660374A1 Antiretroviral solid oral composition |
| 02/14/2008 | CA2659775A1 Aqueous dronabinol formulations |
| 02/14/2008 | CA2659179A1 Stabilization of lorazepam into an orally distegrable dosage form |
| 02/14/2008 | CA2658549A1 Oral disintegrating tablet having masked bitter taste and method for production thereof |
| 02/14/2008 | CA2655509A1 Steroid-containing sustained release intraocular implants and related methods |
| 02/14/2008 | CA2655472A1 Compositions with enhanced elasticizing activity |
| 02/14/2008 | CA2654031A1 Microcapsules with improved shells |
| 02/13/2008 | EP1887015A2 Method for extracting and using new human defence agents and biologically active proteins for treating infections and other illnesses |
| 02/13/2008 | EP1886694A1 Peroral formulation of dienogest and ethinylestradiol for contraception |
| 02/13/2008 | EP1886691A2 A pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug |
| 02/13/2008 | EP1886688A1 Method for producing nucleic acid-containing complex preparation |
| 02/13/2008 | EP1886686A1 Pharmaceutical composition containing mometasone furoate |
| 02/13/2008 | EP1886684A1 Pharmaceutical composition comprising rimonabant |
| 02/13/2008 | EP1886682A1 Method for preparation of aqueous doripenem solution |
| 02/13/2008 | EP1886678A1 Stable tablet containing droxidopa |
| 02/13/2008 | EP1886676A1 Compositions with enhanced elasticizing activity |
| 02/13/2008 | EP1886675A1 Skin patch |
| 02/13/2008 | EP1886674A2 Pharmaceutical composition |
| 02/13/2008 | EP1886673A2 Solid dosage form of enteric solid dispersion and method for producing the same |
| 02/13/2008 | EP1886672A2 Solid dosage form comprising solid dispersion and method for producing the same |
| 02/13/2008 | EP1886671A1 Starch silica co-precipitate, method for preparing the same and use thereof |
| 02/13/2008 | EP1886670A1 Pharmaceutical compositions of memantine |
| 02/13/2008 | EP1886669A2 Phosphoglucan based immunotrophic preparation for the treatment of adenotonsillar hypertrophy |
| 02/13/2008 | EP1886668A1 Controlled release compositions for interferon based on block polymers |
| 02/13/2008 | EP1886667A1 Microemulsified drug formulation |
| 02/13/2008 | EP1886666A1 Method for manufacturing a composite made of oligo- or polynucleotide and hydrophobic biodegradable polymers and composite created according to this method |
| 02/13/2008 | EP1886665A1 Gastro retentive delivery system |
| 02/13/2008 | EP1886662A1 Anti-microbial compounds for treating bad breath |
| 02/13/2008 | EP1886169A2 Ophthalmic devices for sustained delivery of active compounds |
| 02/13/2008 | EP1885721A2 Metal chelates of polyaminocarboxylic macrocyclic derivatives and use thereof in diagnostic imaging |
| 02/13/2008 | EP1885405A1 Method for terminal sterilization of transdermal delivery devices |
| 02/13/2008 | EP1885370A2 Pharmacological modulation of telomere length in cancer cells for prevention and treatment of cancer |
| 02/13/2008 | EP1885345A1 Thin foam coating comprising discrete, closed-cell capsules |
| 02/13/2008 | EP1885344A1 Rapidly dissolving gelatin compositions and products made therefrom |
| 02/13/2008 | EP1885343A2 Oral drug compliance monitoring using radio frequency identification tags |
| 02/13/2008 | EP1885342A1 Crystallization inhibitor and its use in gelatin capsules |
| 02/13/2008 | EP1885341A2 Portable drug delivery device including a detachable and replaceable administration or dosing element |
| 02/13/2008 | EP1885340A1 Modified-release composition of at least one form of venlafaxine |
| 02/13/2008 | EP1885339A2 Formulations of a src/abl inhibitor |
| 02/13/2008 | EP1885338A1 Pharmaceutical compostions comprising an amorphous form of a vegf-r inhibitor |
| 02/13/2008 | EP1885337A2 Medicament, particularly an anti-cancer medicament, for treatment using immunotherapy, particularly autologous |
| 02/13/2008 | EP1885336A2 Suspension formulations comprising an active principle, a poloxamer or meroxapol surfactant and a glycol, its use for the manufacture of a medicament for treating ophthalmic disorders |
| 02/13/2008 | EP1885335A1 Surface-modified microparticles and methods of forming and using the same |
| 02/13/2008 | EP1885334A1 A delivery system for two or more active components as part of an edible composition |
| 02/13/2008 | EP1885333A1 Pharmaceutical formulation of apomorphine for buccal administration |
| 02/13/2008 | EP1885332A2 Use of an artificial sweetener to enhance absorption of nicotine |
| 02/13/2008 | EP1755570B1 Transdermal drug delivery device comprising extensor-relaxor means |
| 02/13/2008 | EP1689370B1 METHOD FOR THE PRODUCTION OF A SOLID, ORALLY APPLICABLE PHARMACEUTICAL COMPOSITION COMPRISING 5-Chlor-N ( { (5-2-oxo-3- [4- (3-oxo-4-morpholinyl)-phenyl]-1, 3- oxazolidin-5-yl}-methyl)-2-thiophencarboxamide |
| 02/13/2008 | EP1667960B1 Meldonium salts, method of their preparation and pharmaceutical composition on their basis |
| 02/13/2008 | EP1617827B1 Pharmaceutical composition in the form of a hydrogel for transdermal administration of active substances |
| 02/13/2008 | EP1572152B1 Liposomal analgesic formulation comprising diclofenac and its use for treatment of horses |
| 02/13/2008 | EP1569664B1 Bioerodible poly(ortho esters) from dioxane-based di(ketene acetals), and block copolymers containing them |
| 02/13/2008 | EP1538921B1 Chewing gum formulation and method of making the same |
| 02/13/2008 | EP1517699B1 Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivation |
| 02/13/2008 | EP1490025B1 Nanoparticulate compositions of map kinase inhibitors |
| 02/13/2008 | EP1441701B1 Montelukast granule formulation |
| 02/13/2008 | EP1436010B1 Water-in-oil emulsions comprising vinyl polymers carrying ethylene oxide groups in side chains, compositions, and methods |
| 02/13/2008 | EP1427397B1 Oily thixotropic formulations |
| 02/13/2008 | EP1411923B1 Pharmaceutical compositions of amlodipine and atorvastatin |
| 02/13/2008 | EP1343450B1 Remineralising dental adhesive film |